This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reef, S. E.
Right arrow Articles by Jarvis, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reef, S. E.
Right arrow Articles by Jarvis, W. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 1998, p. 1255-1259, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Nonperinatal Nosocomial Transmission of Candida albicans in a Neonatal Intensive Care Unit: Prospective Study

Susan E. Reef,1,dagger Brent A. Lasker,1,* Dona S. Butcher,2 Michael M. McNeil,1 Ruth Pruitt,1 Harry Keyserling,3 and William R. Jarvis4

Division of Bacterial and Mycotic Diseases1 and Hospital Infections Program,4 Centers for Disease Control and Prevention, Atlanta, Georgia 30333, and Divisions of Neonatology2 and Pediatric Infectious Diseases and Immunology,3 Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322

Received 15 September 1997/Returned for modification 28 November 1997/Accepted 27 January 1998

Nosocomial Candida albicans infections have become a major cause of morbidity and mortality in neonates in neonatal intensive care units (NICUs). To determine the possible modes of acquisition of C. albicans in hospitalized neonates, we conducted a prospective study at Grady Memorial Hospital, Atlanta, Ga. Clinical samples for fungal surveillance cultures were obtained at birth from infants (mouth, umbilicus, and groin) and their mothers (mouth and vagina) and were obtained from infants weekly until they were discharged. All infants were culture negative for C. albicans at birth. Six infants acquired C. albicans during their NICU stay. Thirty-four (53%) of 64 mothers were C. albicans positive (positive at the mouth, n = 26; positive at the vagina, n = 18; positive at both sites, n = 10) at the time of the infant's delivery. A total of 49 C. albicans isolates were analyzed by restriction endonuclease analysis and restriction fragment length polymorphism analysis by using genomic blots hybridized with the CARE-2 probe. Of the mothers positive for C. albicans, 3 of 10 were colonized with identical strains at two different body sites, whereas 7 of 10 harbored nonidentical strains at the two different body sites. Four of six infants who acquired C. albicans colonization in the NICU had C. albicans-positive mothers; specimens from all mother-infant pairs had different restriction endonuclease and CARE-2 hybridization profiles. One C. albicans-colonized infant developed candidemia; the colonizing and infecting strains had identical banding patterns. Our study indicates that nonperinatal nosocomial transmission of C. albicans is the predominant mode of acquisition by neonates in NICUs at this hospital; mothers may be colonized with multiple strains of C. albicans simultaneously; colonizing C. albicans strains can cause invasive disease in neonates; and molecular biology-based techniques are necessary to determine the epidemiologic relatedness of maternal and infant C. albicans isolates and to facilitate determination of the mode of transmission.


* Corresponding author. Mailing address: Division of Bacterial and Mycotic Diseases, Building 1, Room 2225, Mailstop D-11, 1600 Clifton Rd., Centers for Disease Control and Prevention, Atlanta, GA 30333. Phone: (404) 639-2842. Fax: (404) 639-4421. E-mail: BAL3{at}CDC.GOV.

dagger Present address: National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333.


Journal of Clinical Microbiology, May 1998, p. 1255-1259, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Radke, M., Blaut, M. (2006). Effects of Bifidobacterium lactis Bb12 Supplementation on Intestinal Microbiota of Preterm Infants: a Double-Blind, Placebo-Controlled, Randomized Study. J. Clin. Microbiol. 44: 4025-4031 [Abstract] [Full Text]  
  • Sarvikivi, E., Lyytikainen, O., Soll, D. R., Pujol, C., Pfaller, M. A., Richardson, M., Koukila-Kahkola, P., Luukkainen, P., Saxen, H. (2005). Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit. J. Clin. Microbiol. 43: 2729-2735 [Abstract] [Full Text]  
  • Roilides, E., Farmaki, E., Evdoridou, J., Francesconi, A., Kasai, M., Filioti, J., Tsivitanidou, M., Sofianou, D., Kremenopoulos, G., Walsh, T. J. (2003). Candida tropicalis in a Neonatal Intensive Care Unit: Epidemiologic and Molecular Analysis of an Outbreak of Infection with an Uncommon Neonatal Pathogen. J. Clin. Microbiol. 41: 735-741 [Abstract] [Full Text]  
  • Soll, D. R. (2000). The Ins and Outs of DNA Fingerprinting the Infectious Fungi. Clin. Microbiol. Rev. 13: 332-370 [Abstract] [Full Text]  
  • Marco, F., Lockhart, S. R., Pfaller, M. A., Pujol, C., Rangel-Frausto, M. S., Wiblin, T., Blumberg, H. M., Edwards, J. E., Jarvis, W., Saiman, L., Patterson, J. E., Rinaldi, M. G., Wenzel, R. P., The Nemis Study Group, , Soll, D. R. (1999). Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3. J. Clin. Microbiol. 37: 2817-2828 [Abstract] [Full Text]